Although previous research has demonstrated the key role of the oocyte-derived factors, bone morphogenetic protein (BMP) 15 and growth differentiation factor (GDF) 9, in follicular development and ovulation, there is a lack of knowledge on the impact of external factors, which females are exposed to during folliculogenesis, on their expression. The present study investigated the effect of the aphrodisiac Tribulus terrestris on the GDF9 and BMP15 expression in the oocytes and cumulus cells at mRNA and protein levels during folliculogenesis in two generations of female rabbits. The experiment was conducted with 28 New Zealand rabbits. Only the diet of the experimental mothers group was supplemented with a dry extract of T. terrestris for the 45 days prior to insemination. The expression of BMP15 and GDF9 genes in the oocytes and cumulus cells of mothers and F1 female offspring was analyzed using real-time polymerase chain reaction (RT-PCR). The localization of the GDF9 and BMP15 proteins in the ovary tissues was determined by immunohistochemical analysis. The BMP15 and GDF9 transcripts were detected in the oocytes and cumulus cells of rabbits from all groups. T. terrestris caused a decrease in the BMP15 mRNA level in the oocytes and an increase in the cumulus cells. The GDF9 mRNA level increased significantly in both oocytes and cumulus cells. The downregulated expression of BMP15 in the treated mothers’ oocytes was inherited in the F1 female offspring born to treated mothers. BMP15 and GDF9 show a clearly expressed sensitivity to the bioactive compounds of T. terrestris.
Citation: Abadjieva D, Kistanova E (2016) Tribulus terrestris Alters the Expression of Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 in Rabbit Ovaries of Mothers and F1 Female Offspring. PLoS ONE 11(2): e0150400. doi:10.1371/journal.pone.0150400
Editor: Qing-Yuan Sun, Institute of Zoology, Chinese Academy of Sciences, CHINA
Received: January 20, 2016; Accepted: February 15, 2016; Published: February 29, 2016
Copyright: © 2016 Abadjieva, Kistanova. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: Funding provided by the Seventh frame work program (FP7), ReProForce, GA245641—EK, DA, and a FP7 Post-Grant Open Access Pilot "Support in charging of publication fee." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The plant, Tribulus terrestris (TT), is used in the industrial production of medical preparations and feed additives based on its saponin fraction . The dry extract of TT is extremely rich in substances having potential biological significance, such as flavonoids, alkaloids , glycosides, and phytosteroids [3–5]. Since ancient times, T. terrestris is known as an aphrodisiac herb with stimulating effects on the androgenic metabolism in humans and male animals [6–11]. Recent studies show that this plant can also influence female reproduction and improve female sexual dysfunction . Oral treatment of aqueous extracts of TT increases the number of growing follicles in mice, but without significant effect on the sex hormone levels . The increase in egg production in Guinea fowls treated with TT extract report .  showed higher numbers of yellow bodies in the ovaries of treated immature rats as an evidence of LH-like activity of TT, causing puberty onset. Moreover, TT was suggested as an alternative treatment for polycystic ovary disease. A high dose of the extract can efficiently remove ovarian cysts and resume ovarian activity [16–17]. It seems that TT affects folliculogenesis in females; however, limited information is available in this regard and the mechanisms underlying the action of TT remain unknown.
It is well known that two oocyte-specific genes, growth differentiation factor 9 (GDF9) and bone morphogeneticprotein 15 (BMP15), play a key role in the regulation of folliculogenesis in many species. These factors induce the proliferation and differentiation of the follicular cells during follicular development from the primordial stage [18–19]. In addition, they are involved in the final events of maturation and ovulation, such as cumulus cell expansion and yellow body formation [20–22]. For efficient female fertility, a precisely balanced level of BMP15 and GDF9 expression in oocytes is required . These processes are controlled and coordinated by mutually dependent actions between oocytes and cumulus cells . Evidence of the importance of BMP15 and GDF9 in female fertility was obtained through experiments with knockout and transgenic animals [25–27], analyses of the gene mutations in ewes and humans [28–31], as well as through in vitro experiments with oocytes-cumulus complexes [32–34]. However, there is a lack of knowledge on how external factors affect the expression of these oocyte-derived growth factors, particularly the nutritional factors that animals are exposed to during folliculogenesis.
There are only few in vivo studies available in this field. A previous study , showed that a 40% calorie restriction in mice led to a decline in the expression of GDF9 in the ovaries; however, a contrasting data was provided by another study : no differences were observed in the GDF9 and BMP15 mRNA levels in the oocytes of ewes exposed to the high and low energy diets for two weeks before superovulation. In rabbits, a previous study  examined the effect of moderate and severe dietary feed restriction (21 days), followed by refeeding (8 days), on GDF-9 gene expression in mature and immature oocytes. They established an enhanced percentage of mature oocytes, accompanied by a significant increase in GDF-9-mRNA levels in oocytes after refeeding. In contrast, another study  did not observe any change in the mRNA levels of GDF9 and BMP15 from whole ovaries of rabbits fed on a high fat, high cholesterol diet.
Considering the pivotal role of the paracrine factors GDF9 and BMP15 in folliculogenesis from the primordial stage until ovulation, we hypothesize that the biological active compounds of TT affect their expression through metabolic pathways. To test this hypothesis, we aimed to evaluate the growth factors, GDF9 and BMP15, at mRNA and protein levels to determine: a) how TT affects folliculogenesis and ovulation rates in rabbit-mothers and b) how TT impacts the ovaries of F1 female offspring born to the treated mothers.
Materials and Methods
Experimental design for animals
The investigations were conducted with 28 female white New Zealand rabbits in the animal facility of the Institute of Biology and Immunology of Reproduction, Sofia, Bulgaria. The experiment started with 14 sexually mature does (mothers generation) randomly divided in the control and experimental groups of 7 females each. The animals from the experimental group were individually provided the feed additive, VemoHerb-T (VHT, producer Vemo-Ltd, Bulgaria), with their drinking water, in daily doses of 3.5 mg/kg body weight for 45 days prior to insemination. The VHT preparation contained a dry extract of Tribulus terrestris with the following active substances: 60% furostanol saponins, determined as protodioscin; flavonoids—10.0%; tannic compounds—tannin—10.0%. Both groups were fed with standard diet for mature rabbits. At the end of the experimental period, female rabbits from both groups were mated with one control male rabbit. The number and survivability of offspring were estimated. The animals from the parental generation were slaughtered, after weaning of the offspring, for ovary collection.
Among the female newborns (F1 female generation), two new groups were formed, control and experimental, of 7 females each to the origin from the mothers’ generation. The animals were fed standard diet and kept in the same conditions as the mothers’ generation, but without VHT additive, until puberty onset (6 months old) and were slaughtered thereafter for ovary collection.
All animals were reared and handled in accordance with the Bulgarian Veterinary Law (25/01/2011), in terms of the life conditions and welfare of experimental animals, adapted to the European Union regulation 86/609. In accordance with the Bulgarian Veterinary Law (Regulation N20 /01.11.2012 based on the Directive 2010/63/EU on the protection of animals used for scientific purposes in the Member States), only the National Ethics commission for animals can approve the use of animas for scientific purposes. The present study is one of the planned institutional projects for the period 2013–2018 and its protocol has been approved by the National Ethics commission for animals within the delivered permission of use of the animals in the experiments" (N84/04.10.2013, expiry date 04.10.2018). The responsible person for animal welfare at the Institute, working directly with the animals, is licensed by Bulgarian veterinary services for animal experimentation. The slaughtering of animals was performed after previously anesthetizing with 2% xylazine. All efforts were made to minimize suffering.
Ovaries removed from the slaughtered animals were kept in PBS and brought to the laboratory immediately. One ovary from each animal was used for the collection of oocytes and cumulus cells. The cumulus-oocyte complexes (COCs) were aspirated by puncturing the follicles (diameter ≥2 mm) and collected under the stereomicroscope SMZ-10 (Nikon, Japan). Firmly compacted COCs with multilayered cumulus cells and a uniformly granulated cytoplasm were separated into oocytes and cumulus cells by repeated aspiration using a narrow-bore Pasteur pipette. Final denudation of the oocytes was performed by hyaluronidase treatment (Sigma-Aldrich; at a working concentration of 300 μg/mL), followed by washing thrice in PBS. The collected samples were stored at -80°C until RNA extraction.
Extraction and Purification of Total RNA and First-strand cDNA Synthesis
Total RNA was isolated from cumulus cells and oocytes separately for each animal, using a commercial RNA purification kit (NORGEN, 17200, Canada). A 1-μL volume of the solution was used for a concentration test and examination of the RNA integrity with a Qubit RNA Assay Kit (Invitrogen, Q32852). The extracted RNA was kept at –70°C.
The first strand of cDNAs was synthesized by the kit “Easy Script Plus Reverse Transcriptase“(G177, abm, Canada), according to the manufacturer’s instructions using the oligo dT and random primers mix included in the kit.
Real Time PCR
The analysis of the GDF9 and BMP15 gene expressions in oocytes and cumulus cells was performed by RT-PCR using two sets of primers, GDF9-forward primer: 5′-AAAGACCAGCTGCAGCATCC-3′and reverse primer: 5′-TGGTGTGAACTGGAGAGCCA-3′; BMP15-forward primer: 5′-GCTGGGATCACTGGATCATT-3′ and reverse primer: 5′- TGTACAGGACTGGGCAATCA -3′. All primers were commercially synthesized (Sigma-Aldrich, USA).
PCR amplification was performed under the following conditions: predenaturation at 95°C for 10 min; 40 cycles for each sample that comprised an initial denaturation step at 95°C for 5 s, annealing at 60°C for 20 s, and extension at 60°C for 30 s. Rabbit glyceraldehyde-3-phosphate dehydrogenase (GAPDH- forward primer: AAGGTCATCCACGACCACTT; GAPDH- reverse primer: AGGCCATGCCAGTGAGT; Sigma-Aldrich, USA) was used as a control gene for PCR. At the same time, negative controls (without cDNA template), with cDNA substituted for water, were set up for comparison. Each sample was run in triplicate. The cycle threshold values (CT) indicated the quantity of the target gene in each sample and the sequence of the target gene was determined in realtime using an Mx3005P QPCR system (Stratagene, LaJolla, CA, USA).
In order to correct the inter-run fluctuations, standard curves were generated for each gene by serial dilution of the mix cDNA samples (1, 1:5, 1:25, 1:125, 1:625, and 1:3125). A 2-μL volume of each concentration was used as a sample separately for the construction of GDF9, BMP15, and GAPDH gene standard curves.
The second ovary of each animal was fixed with 10% formaldehyde PBS and subsequently dehydrated and embedded in paraffin. Serial sections of 5-μm thickness were cut by using a microtome type 2125RT (Leica GmbH, Germany). The histological estimation of the folliculogenesis was done by counting the number of the different classes of follicles per μm.
For the detection and analysis of GDF9 and BMP15 proteins, the immunohistochemical technique described by  was performed using commercial antibodies. Simultaneously, immunohistochemical-negative controls were carried out using an irrelevant IgG. Briefly, sections were blocked with 3% hydrogen peroxide for 15 min and kept in 10% donkey serum for 1 h at room temperature. The primary antibodies goat polyclonal anti-human, in working dilution GDF-9 1:100 or BMP15 1:100 (GDF9, code sc-12244; BMP15, code sc- 18337, Santa Cruz Biotechnology, Inc.; Santa Cruz, CA, U.S.A.) were used for incubation over night at 4°C. The primary antibody reaction was achieved using donkey anti-goat biotinylated secondary antibodies in a working dilution of 1:200 (code sc-2023) for 1 h, followed by avidin-biotin complex (1:1000; code PK-6100, Vector, USA) for 1 h. Finally, the binding was visualized by the addition of 3,3′-diaminobenzidine (DAB) chromogen solution (1:200; code SK-4105, Vector, USA) for 10 min. After counterstaining with hematoxylin (Vecto, USA), the sections were observed with an Olympus BX51 (Olympus, Tokyo, Japan) and images were taken with a Powershot G6, 7.1 megapixels digital camera (Canon Inc., Japan).
Depending on the sample number and normality of distribution, parametric and non-parametric statistics were used. For n > 30 and normal distributions, Student’s t-test was applied. In all other cases, the Wilcoxon rank-sum test was used to estimate the significance of results.
The data from PCR were developed by DataAssist Sft. (Ver. 3. 01, Applied Biosystems) using the ΔCt method . The quantifying results of copy numbers of BMP15 and GDF9 mRNA were expressed as a mean of the ratio of target genes to the control gene—GAPDH. For the evaluation of the feed additive effect, the ΔΔCt method was applied for the comparison between the control and the experimental groups . The fold change (FC) against the control group ≥ 2 and p value ≤ 0.05 were considered as an up-regulation; FC ≤ 0.5 and p ≤ 0.05 were considered as downregulation. Genes with a FC between 0.5 and 2 were considered to indicate no significant change.
The immunostaining reaction was evaluated on representative fields of the ovary slices. Immunoreactivity of GDF9 and BMP15 was assessed as a percent of the staining intensity of the positive cells inside a defined area (μm2), using the software program ImageJ. A t-test was used to compare the results between control and experimental groups. Statistical significance was set at p < 0.05.
Supplementation of VHT in the rabbit mothers’ diet led to an increase in ovary weight in both generations of female rabbits. VHT did not affect fertility; the number of offspring born was similar to that of the control group (S1 Table). However, the survivability of newborns of treated mothers was higher than that of the control group (S1 Fig). The density of the primary and secondary follicles in the ovaries of the treated mothers’ generation and the density of the preantral follicles in the ovaries of F1 females born to the treated mothers were higher than those in the controls (S2 Table).
In the oocytes and cumulus cells collected from all does, both BMP15 and GDF9 transcripts were detected. There were the differences in the expression of the investigated genes between generations. BMP15 and GDF9 expression in the oocytes of control F1 females’ ovaries was higher than that in the control mothers’ ovaries (Fig 1A). A remarkable difference was observed in the expression of GDF9; the mRNA level of GDF9 in the oocytes of the F1 generations’ ovaries was several times higher than those in the mothers’ ovaries. In contrast, the expression of BMP15 and GDF9 in the cumulus cells of rabbit-mothers’ ovaries and F1 females was not significantly different (Fig 1B).
mRNA level of GDF9 and BMP15 in the oocytes (A) and cumulus cells (B) of the female rabbits in dependence on age. The results were obtained by comparison of the control groups from both generations–does-mothers and F1 female offspring. Total RNA was extracted from the oocytes and cumulus cells and subjected to real-time PCR to determine the mRNA levels of BMP15 and GDF9. The expression of these mRNAs was normalized to the expression of control gene GAPDH. The triplicates for each reaction were averaged. This data represent the mean ±SEM of the combined results from the analysis of seven rabbits from each group (*, P < 0.05). The significantly higher expression of BMP15 and GDF9 in the oocytes from the ovaries of F1 female compared to the mothers' generation was observed.
Supplementation of the rabbit-mothers’ diet with the feed additive VHT led to a decrease in the BMP15 mRNA level in the oocytes and an increase in its level in the cumulus cells (Fig 2A). The significant increase in GDF9 mRNA levels in both oocytes and cumulus cells was observed in the ovary of mothers treated with VHT (Fig 2C).
(A) and (C) mothers’ generation; (B) and (D) F1 female generation. The only experimental group of the mothers’ generation was treated with feed additive VemoHerb-T (dry extract of plant Tribulus terrestris, producer Vemo-Ltd) during 45 days prior to insemination. Total RNA was extracted from the oocytes and cumulus cells and subjected to real-time PCR to determine the mRNA levels of BMP15 and GDF9. The expression of these mRNAs was normalized to the expression of control gene GAPDH. Data are shown as a relative ratio (fold change—FC) of the mRNA level of these genes in the experimental groups to the controls of each generation. These data represent the mean ±SEM of the combined results from the analysis of seven rabbits from each group (*- significance P < 0.05, compared to control). T. terrestris caused a decrease in the BMP15 mRNA level in the oocytes and an increase in the cumulus cells. The GDF9 mRNA level increased significantly in both oocytes and cumulus cells. The downregulated expression of BMP15 in the treated mothers’ oocytes was inherited in the F1 female offspring born to treated mothers.
The expression level of mRNA in the investigated genes was lower in both oocytes and cumulus cells in the ovaries of F1 females’ offspring born to experimental mothers compared to the F1 females born to the controls (Fig 2B and 2D). We noticed down-regulation of BMP15 in oocytes of the offspring (FC = 0.12, P < 0.05) and GDF9 in cumulus cells (FC = 0.25, P < 0.05).
The direct effect of the VHT supplementation on the expression of BMP15 and GDF9 genes in the oocytes and cumulus cells of the treated mothers was several times higher than that in the F1 female offspring born to them (Table 1).
Both the investigated genes demonstrated sensitivity to VHT treatment. However, a more powerful impact of VHT on the GDF9 gene expression in the cumulus cells of mothers’ ovaries was observed.
The localization of BMP15 and GDF9 proteins was determined by immunohistochemistry.
Immunopositive signals of BMP15 and GDF9 were detected in the oocytes and cumulus cells of the follicles in the ovaries of mothers and F1 females’ (Figs 3 and 4) from both groups, control and experimental. In addition, both growth factors were detected in the theca, interstitial, and corpus lutein cells.
Localization of the protein BMP15 in: (a) oocytes of the primordial and primary follicles in the VHT-treated mothers ovary; (b) granulosa cells of the tertiary follicle in the VHT- treated mothers ovary; (c) primordial and primary follicles—negative control of antibody; (d) oocytes of primordial and primary follicles in the ovary of F1 offspring born to treated mothers; (e) oocytes and granulosa cells of the antral follicle in the ovary of F1 offspring born to treated mothers; (f) mouse testis—positive control of antibody; (g) Original magnification: (a–f) × 20.
Localization of the protein GDF9 in: (a) oocytes of the primordial and primary follicles in the VHT-treated mothers ovary; (b) oocytes and granulosa cells of the early antral follicle in theVHT- treated mothers ovary; (c) antral follicle- negative control of antibody; (d) oocytes of primary and primordial follicles in the ovary of F1 offspring born to treated mothers; (e) oocyte and cumulus-granulosa cells of the antral follicle in the ovary of F1 offspring born to treated mothers; (f) mouse ovary—positive control of antibody; (g) Original magnification: (a–f) × 20.
The computer estimated immune staining intensity of the investigated proteins had shown the most intensive signals of BMP15 (Fig 5) and GDF9 (Fig 6) in the oocytes from primordial and primary follicles and the lowest in the oocytes from antral follicles in all groups. Significantly higher signals for both proteins were observed in the primary and secondary oocytes from ovaries of the mothers treated with VHT. The increased secretion of GDF9 in the oocytes from antral follicles of treated mothers’ ovaries corresponded with the results of mRNA level changes obtained by PCR, whereas the results related to the BMP15 signals in the oocytes are somewhat contradictory. Although the level of BMP15 mRNA in the oocytes of treated mothers decreased, there were no differences in the intensity of protein signals compared to the control oocytes. It is likely that a reverse of the protein BMP15 from cumulus cells to oocytes occurred due to a deficit in mRNA production in the oocytes. Thus, the BMP15 protein expression was significantly higher in the cumulus cells of the antral follicles in both experimental groups F0 mothers and F1 female offspring generations (Fig 5).
Control M–mothers generation; Control F1- female offspring born to the control mothers; VHT-M- VemoHerb-T treated mothers; VHT-F1- female offspring born to the treated mothers; 0-I–primordial and primary follicles; II-III–secondary and preantral follicles; IV–antral follicles. *—significant differences, p < 0.05. Protein expression was estimated by the program ImageJ based on the intensity of immunostaining reactions on the defined square. At least 5 slides per animal were analysed. Significantly intensive signals were detected in the oocytes from primordial and primary follicles in the ovaries of treated mothers as well as in the cumulus cells from the antral follicles of F1 females born to the treated mothers.
Control M–mothers generation (n = 7); Control F1- female offspring born to the control mothers (n = 7); VHT-M- VemoHerb-T treated mothers (n = 7); VHT-F1- female offspring born to the treated mothers (n = 7); 0-I–primordial and primary follicles; II-III–secondary and preantral follicles; IV–antral follicles. *—significant differences, p < 0.05. Protein expression was estimated by the program ImageJ based on the intensity of immunostaining reactions on the defined square. At least 5 slides per animal were analysed. Significantly intensive signals were detected in the oocytes from primordial, primary and secondary follicles in the ovaries of threated mothers as well as in the oocytes from secondary follicles of F1 females born to the treated mothers.
In the cumulus cells, the intensity of BMP15 and GDF9 signals increased from primary to secondary and preantral follicles and decreased again to antral follicles. The more intense GDF9-signals were detected in the cumulus cells from the secondary follicles of the treated mothers (Fig 6).
Previous studies have shown that GDF9 and BMP15 have distinct effects on the reproductive physiology in a species-specific manner . Considering this, it is very important to collect data on BMP15 and GDF9 actions in the ovaries of different animal species. To our knowledge, our study was the first in vivo study describing the changes in the expression of the growth factors BMP15 and GDF9 at mRNA and protein level in the follicular structures of female rabbits in two generations–mothers and F1 female offspring–as a result of supplementation of dry extract of T. terrestris to mothers’ diet 45 days prior to insemination. The obtained data demonstrated the clearly expressed sensitivity of the BMP15 and GDF9 to the bioactive compounds of T. terrestris.
T. terrestris is one of the most popular phyto-aphrodisiac for male reproduction. Although the long-term use of this plant improves sexual performance in males, there is no consensus on the exact mechanisms of TT action in the organism. It is believed that steroidal saponins present in TT extracts can enhance the endogenous androgen production by increasing luteinizing hormone release from the pituitary gland . Another hypothesis proposes that TT bioactive compounds might be enzymatically converted into weak androgens such as dehydroepiandrosterone, which could be converted into more potent androgens such as testosterone or estradiol in the gonads . The potential application of TT as an alternative therapy for the sexual dysfunction in women  as well as the evidence of its ability to remove ovarian cysts  has led to increased research on this plant focusing on female reproduction.
Our results show the stimulating effect of the additive VemoHerb-T on the weight of rabbit mothers’ ovary and weight of the offspring. Similar results were observed in mice  and in Guinea fowls  treated with the extract of TT. Moreover, the treated mother does in our experiment expressed more pronounced maternal instincts than the controls. They more actively prepared the nests and took thorough care of the pups. The Kaplan-Meier analysis confirmed a higher survivability of newborns to experimental mothers. Considering that such maternal behavioral reactions are related to the action of estrogens on the central nervous system , our results indicate an enhanced level of estrogens in the ovary of treated mothers. Our results are consistent with a previous study , which demonstrates an increase in the luteinizing hormone level in female rats treated with TT. The LH-like effect of T. terrestris on rats’ ovaries has been demonstrated in a previous study . It is known that LH can stimulate estradiol production in the ovary by the activation of the aromatase pathway . An enhanced level of estradiol was reported in women who used the preparation Tribestan (pills containing the dry extract of TT); despite the suppression of FSH production, the secretion of estradiol and progesterone did not decrease in women treated with Tribestan .
However, it is impossible to explain all morphological changes in the ovaries of experimental animals, particularly the increase in the density of secondary follicles, by the hormonal changes only, because at this stage they are not sensitive to hormones. Similar to the present study, an enhanced number of secondary follicles in the ovaries of TT treated rat was found in a previous study . These results can be explained on the basis of our data, which demonstrated the changes in the expression of growth factors BMP15 and GDF9 in the oocytes and cumulus cells under TT treatment.
Currently existing literature related to rodents mainly provides information on the expression of GDF9 and BMP15 genes in the oocytes [47, 26]. In our in vivo experiments, we established new insights that the transcripts of BMP15 and GDF9 were detected in both oocytes and cumulus cells in the ovaries of all adult and young rabbits. Their expression was higher in the oocytes of young animals, whereas the expression in the cumulus cells exhibited no significant difference between the young and adults. These results correspond with the results of previous studies on the age-associated profiles of BMP15 and GDF9. Significant BMP15 gene expression in rabbit ovaries from 14 d post parturition were observed, when primordial follicles were clearly detected . The highest level was measured at 60 d post parturition and a lower level was detected in adult animals. Similar results were obtained during the investigation of gene profiles in the oocytes from young and adult mice [49,35]. Our results confirmed the findings of a previous study  that GDF9 expression is higher in the oocytes of young calves than in adult cows. However, our results differ from the results of that study  in terms of age-associated BMP15 expression in bovine oocytes and cumulus cells.
We established the presence of BMP15 and GDF9 proteins in the follicles at all stages of development as well as in the interstitial and corpus lutein cells, which strongly suggest their pivotal role in the whole process of folliculogenesis in rabbits and confirms the previous investigations in other rodents [27, 32].
In the present study, the alteration in the expression of the BMP15 and GDF9 genes, as a result of the supplementation of feed additive VHT to the mothers’ diet, indicated their high sensitivity to metabolic changes in the ovaries. These findings are consistent with those of previous studies [35, 37], in which the calorie restriction in mice, as well as the feed restriction and refeeding in rabbits lead to changes in GDF9 expression in the ovaries. In our study, T. terrestris caused the alteration of mRNA levels of both genes, but in different ways. Although we noticed a downregulation of BMP15 in the oocytes of treated mothers, we did not observe any failure in their fertility. This corresponds with the conclusion of  that in rodents, BMP15 is only partially required for ovulation and fertilization. Nevertheless, the observed increase in BMP15 mRNA level in the cumulus cells possibly compensates the lack of BMP15 expression in the oocytes.
Additionally, we found a significant upregulation of the GDF9 gene in the oocytes and cumulus cells of treated mothers. GDF9 is the closest homolog to BMP15 (known as GDF9B). Both bind to the same type II receptor, BMPRIIB, which is essential for GDF9/BMP15 signaling in granulosa cells [51, 19] and show synergism or have similar activity during folliculogenesis . Moreover, GDF9 supports embryo development and fetal viability . It is likely that these biological functions of GDF9 facilitated increased fertility in our experimental animals, despite the decreased level of BMP15 mRNA in the oocytes.
The morphological changes in the treated rabbits’ ovaries followed the changes in the expression of growth factors. There is substantial evidence in several mammalian species that GDF9 is essential for the early stages of follicle development . The increased level of GDF9 in our study ensured a more active involvement of the ovarian reserve in the development. We observed a higher density of primary and secondary follicles in the ovary of the mothers treated with TT. In addition, the diameter of secondary and preantral follicles was higher than that in controls (unpublished data). This is likely due to the ability of GDF9 to regulate granulosa cell mitosis through both, Smad-dependent and independent signaling pathways .
To our knowledge, this is the first study to demonstrate that T. terrestris causes a significant increase in GDF9 at the mRNA and protein levels in the oocytes and cumulus cells of rabbits. These results provide additional value to the explanation of the therapeutic effect of TT described in previous studies [12, 16] in females, because the lack of GDF9 leads to several types of ovarian disorders. It was reported that ovaries from 25- to 31-week-old female GDF9 null mice contain either single unilateral or bilateral ovarian follicular cysts, lined by several layers of flattened granulosa cells . In addition, research on ovary tissues from women with polycystic ovary syndrome (PCOS) revealed that GDF9 mRNA expression is substantially delayed and reduced during the growth and differentiation phase  and cannot reach the normal level even after ovarian stimulation, which is the premise for impaired oocyte quality and developmental competence in PCOS females . The increased level of GDF9 mRNA in the ovaries of animals treated with TT should be the main reason for the success of TT in removing ovarian cysts . Additionally, the GDF9 acting in theca cells regulates androgen production and subsequently affects granulosa cells in different ways–by facilitating granulosa cell estrogen production from androgen aromatization, or by ensuring direct effects of androgens on granulosa cell growth through the androgen receptor that is expressed in granulosa cells [34, 52].
If we accept the mainly discussed hypothesis that TT acts like the LH-hormone, a high level of GDF9 is also essential for modulating the LH receptors to ensure an adequate reaction to the hormone, because the oocyte-secreted factors, GDF9 and BMP15, have an effect on FSH and LH through the expression of their receptors on target cells [57–59]. Therefore, the upregulation of GDF9 in the oocytes and cumulus cells caused by TT explains the consequences of TT action. However, the exact mechanism underlying the increase in GDF9 level remains unclear and requires further investigations.
The analysis of mRNA levels of BMP15 and GDF9 in the oocytes and cumulus cells of F1 female offspring showed heritable changes in the BMP15 gene function. The down regulation of this gene was expressed also in the oocytes of F1 females born to treated mothers. Our results strongly suggest that rabbit’s oocytes are susceptible to epigenetic modulations during folliculogenesis and that the bioactive supplement VHT should be one of the factors causing this transgenerational epigenetic effect related to BMP15. Epigenetic processes can occur due to the direct exposure to external factors at critical periods, particularly during sensitive developmental windows for the germ cells, such as folliculogenesis . Nutrition, as an environmental factor, affects oocytes. Therefore, changes in the environment surrounding oocytes can alter the pattern of genes expressed by these structures, with consequences for both immediate and longer-term development . Despite the fact that rabbits belong to a group of mammals that do not ovulate spontaneously, it is known that follicles develop and regress in cycles of 15−16 days. It seems that the exposure of the rabbit mothers to the bioactive supplement TT during 45 days of the periconceptual period was sufficient to induce changes in the oocytes-secreted gene BMP15. It is likely that the pathways of TT action on the investigated growth factors are different. The upregulation of GDF9 mRNA in the oocytes and cumulus cells stimulated by TT was not inherited in F1 females; moreover, we observed a lower level of GDF9 mRNA in the oocytes and cumulus cells of these animals compared to the F1 females born to the control mothers.
The present study provides for the first time the evidence for the stimulating effect of TT on the expression of GDF9 and BMP15 at mRNA and protein levels in the oocytes and cumulus cells of rabbits in two generations. The results indicate that these growth factors are sensitive to the bioactive compounds of TT in different ways at different follicle structures. At the same time, GDF9 and BMP15 showed their interchangeability in rabbits. Therefore, overexpression of GDF9 in the case of BMP15 suppression ensured normal development and ovulation of the follicles and high fertility at the first insemination after the treatment.
The present study provides insights into the therapeutic effect of the plant T. terrestris on female reproduction at the molecular level. Further studies are required to elucidate the exact pathways of TT action on growth factors expression, as well as on the epigenetic mechanisms of the influence of TT on F1 female offspring.
S1 Table. Effect of VHT supplementation to the mothers’ diet on reproductive parameters.
The experimental group of mothers was treated with the feed additive VemoHerb-T (dry extract of the plant Tribulus terrestris, producer Vemo-Ltd) 45 days prior to insemination. Both groups were mated with the same male rabbit. Data are presented as a mean ± SEM; Wilcoxon rank-sum test was used for the significance consideration.
S2 Table. Density of different class follicles in the ovaries of control and experimental rabbits.
Serial 5-μm sections in 25 μm depth of each ovary were analyzed. Data are presented as mean ±SEM, t-test was applied, and the differences were considered significant at p < 0.05.
S1 Fig. Kaplan-Meier analysis of the F1 offspring survivability born to control and to mothers’ groups treated with VHT.
The experimental group of mothers was treated with the feed additive VemoHerb-T (dry extract of plant the Tribulus terrestris, producer Vemo-Ltd) 45 days prior to insemination. Both groups were mated with the same male rabbit. A significantly higher survivability of F1 offspring born to experimental mothers was observed.
We express our gratitude to S. Hayrabedyan, K.Todorova-Hayrabedyan, Ts.Veleva-Oreshkova, P.Rashev from IBIR-BAS and K.Teerds from Wageningen University for the consultations and advise for the application of the molecular biology and immunohistochemistry methods. We also thank the staff of the department “Embryobiotechnologies in Animals”, IBIR-BAS: M. Chervenkov, L. Dimova, M. Karaivanova, and S. Savova for their assistance during the experiments. The research was developed within the frame of COST Action 1201 “Epiconcept” and we express our special gratitude to the members of this COST Action for the useful discussions of our results during the meetings. The gift of VemoHerb-T feed additive from Vemo-Ltd (Bulgaria) for this study is gratefully acknowledged.
Conceived and designed the experiments: EK DA. Performed the experiments: DA EK. Analyzed the data: EK DA. Contributed reagents/materials/analysis tools: EK DA. Wrote the paper: DA EK. Application of ImageJ software: DA.
- 1. Kostova I, Dinchev D. Saponins in Tribulus terrestris–chemistry and bioactivity. Phytochem Rev. 2005, 4:111–37.
- 2. Sun W, Gao J, Tu G, Guo Z, Zhang Y. A new steroidal saponin from Tribulus terrestris Linn. Natural Product Letters 2002, 16(4): 243–247. pmid:12168759
- 3. Wu G, Jiang F, Jiang S, Zhu D, Wu H, Jiang S. Steroidal glycosides from Tribulus terrestris. Phytochemistry 1996, 42(6): 1677–1681.
- 4. Končić MZ, Tomczyk M. New insights into dietary supplements used in sport: Active substances, pharmacological and side effects. Current Drug Targets 2013, 14(9): 1079–1092. pmid:23574283
- 5. Chhatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological overview of Tribulus terrestris Pharmacogn Rev. 2014 Jan-Jun; 8(15): 45–51. doi: 10.4103/0973-7847.125530.
- 6. Adaikan PG, Gauthaman K, Prasad R.N.V., Ng S.C. Proerectile pharmacological effects of Tribulus terrestris extract on the rabbit corpus cavernosum. Annals of the Academy of Medicine Singapore 2000, 29(1): 22–26.
- 7. Adaikan PG, Gauthaman K, Prasad RNV. History of herbal medicines with an insight on the pharmacological properties of Tribulus terrestris. Aging Male 2001, 4(3):163–169.
- 8. Akram M, Asif HM, Akhtar N, Shah PA, Uzair M, Shaheen G, et al. Tribulus terrestris Linn.: A review article. Journal of Medicinal Plants Research 2011, 5(16):3601–3605.
- 9. Brown GA, Vukovich MD, Martini ER, Kohut ML, Franke WD, Jackson DA, et al. Effects of androstenedioneherbal supplementation on serum sex h hormone concentrations in 30- to 59-year-old men. Int J Vitam Nutr Res.2001,71(5): 293–301. pmid:11725694
- 10. Gauthaman K, Adaikan PG, Prasad RN Aphrodisiac properties of Tribulus Terrestris extract (Protodioscin) in normal and castrated rats. Life Sci. 2002, 71(12):1385–96. pmid:12127159
- 11. Qureshi A, Naughton DP, Petroczi A. A systematic review on the herbal extract Tribulus terrestris and the roots of its putative aphrodisiac and performance enhancing effect. J Diet Suppl. 2014 Mar;11(1):64–79. doi: 10.3109/19390211.2014.887602. pmid:24559105
- 12. Gama C, Lasmar R, Gama G, Abreu C, Nunes C, Geller M et al. Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual Dysfunction. Clinical Medicine Insights: Women’s Health 2014:7 45–50 doi: 10.4137/CMWH.S17853. pmid:25574150
- 13. Adaay MH, Mosa AR. Evaluation of the effect of aqueous extract of Tribulus terrestris on some reproductive parameters in female mice. J. Mater. Environ. Sci. 2012, 3 (6):1153–1162.
- 14. Nikolova M, Grigorova S, Abadjieva D, Penkov D. Investigation of the effect of Tribulus terrestris extract on some characteristics of the reproductive capacity of guinea fowl. Biotechnol. Anim. Husb. 2010, 26: 259–266.
- 15. Esfandiari A, Dehghan A, Sharifi S, Najafi B, Vesali E. Effect of Tribulus terrestris extract on ovarian activity in immature wistar rat: A histological evaluation. Journal of Animal and Veterinary Advances. 2011, 10(7): 883–886.
- 16. Dehghan A, Esfandiari A, Bigdeli SM. Alternative treatment of ovarian cysts with tribulus terrestris extract: A rat model. Reprod Domest Anim. 2012, 47(1):e12–e15. doi: 10.1111/j.1439-0531.2011.01877.x. pmid:21883512
- 17. Sandeep PM, Bovee TF, Sreejith K. Anti-Androgenic Activity of Nardostachys jatamansi DC and Tribulus terrestris L. and Their Beneficial Effects on Polycystic Ovary Syndrome-Induced Rat Models. Metab Syndr Relat Disord. 2015 Aug;13(6):248–54. doi: 10.1089/met.2014.0136. pmid:25919204
- 18. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc. Natl. Acad. Sci. USA 2002, 99: 2890–2894. pmid:11867735
- 19. Paulini F. and Melo E.. The Role of Oocyte-Secreted Factors GDF9 and BMP15 in Follicular Development and Oogenesis. Reprod Dom Anim. 2011, 46:354–361; doi: 10.1111/j.1439-0531.2010.01739.x.
- 20. Gueripel X., Brun V., and Gougeon A.. Oocyte Bone Morphogenetic Protein 15, but not Growth Differentiation Factor 9, Is Increased During Gonadotropin-Induced Follicular Development in the Immature Mouse and Is Associated with Cumulus Oophorus Expansion. Biology of Reproduction 2006, 75:836–843. doi: 10.1095/biolreprod.106.055574. pmid:16943361
- 21. Su YQ, Wu X, O'Brien ML, Pendola FL, Denegre JN, Matzuk MM et al. Synergistic roles of the oocyte-cumulus cell complex in mice: genetic evidence for an oocyte-granulosa cell regulatory loop.Dev Biol. 2004, 276:64–73. doi: 10.1016/j.ydbio.2004.08.020.
- 22. Orisaka M, Orisaka S, Jiang JY, Craig J, Wang Y, Kotsuji F et al. Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage. Mol Endocrinol. 2006, 20(10):2456–2468. pmid:16740654
- 23. Liao WX, Moore RK, Otsuka F, Shimasaki S. Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. Implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J Biol Chem 2003, 278(6):3713–3719. pmid:12446716
- 24. Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA. 2002, 99:8060–8065. pmid:12048244
- 25. Dong JW, Albertini F, Nishimori K, Kumar TR, Lu NF, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996, 383:531–535. pmid:8849725
- 26. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol. Endocrinol. 1999, 13: 1035–1048. pmid:10379900
- 27. McMahon HE, Hashimoto O, Mellon PL, Shimasaki S. Oocyte-specific overexpression of mouse bone morphogenetic protein-15 leads to accelerated folliculogenesis and an early onset of acyclicity in transgenic mice. Endocrinology 2008, 149:2807–2815. doi: 10.1210/en.2007-1550. pmid:18308851
- 28. Galloway SM, McNatty KP, Cambridge LM, Laitinen MPE, Juengel JL, Jokiranta TS et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000, 25: 279–283. pmid:10888873
- 29. Demars J, Fabre S, Sarry J, Rossetti R, Gilbert H, Persani L et al. Genome-wide association studies identify two novel BMP15 mutations responsible for an atypical hyperprolificacy phenotype in sheep. PLoS Genet 2013; 9:e1003482. doi: 10.1371/journal.pgen.1003482. pmid:23637641
- 30. Pasquale E D, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am. J. Hum. Genet. 2004, 75(1): 106–111. pmid:15136966
- 31. Persani L., Rossetti R., Di Pasquale E., Cacciatore C., and Fabre S.. The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders. Human Reproduction Update 2014, 20(6): 869–883. doi: 10.1093/humupd/dmu036. pmid:24980253
- 32. Yan CP, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV et al. Synergistic Roles of Bone Morphogenetic Protein 15 and Growth Differentiation Factor 9 in Ovarian Function. Molecular Endocrinology 2001, 15(6): 854–866. pmid:11376106
- 33. Ping Y, Jing-Giang JI, Lin L, Jia-Tong D. Cloning of Rabbit Bone Morphogenetic Protein 15 and Its Expression During in vitro Maturation of Rabbit Oocytes. Zoological Research. 2008, (6): 603–607.
- 34. Sugiura K, Su Y-Q, Li Q, Wigglesworth K, Matzuk M, Eppig J. Estrogen Promotes the Development of Mouse Cumulus Cells in Coordination with Oocyte-Derived GDF9 and BMP15. Mol Endocrinol. 2010, 24(12):2303–2314. doi: 10.1210/me.2010-0260. pmid:21047911
- 35. Sharov A, Falco G, Piao Y, Poosala S, Becker K, Zonderman A et al. Effects of aging and calorie restriction on the global gene expression profiles of mouse testis and ovary. BMC Biology 2008, 6:24 doi: 10.1186/1741-7007-6-24. pmid:18522719
- 36. Pisani LF, Antonini S, Pocar P, Ferrari S, Brevini TA, Rhind SM et al. Effects of premating nutrition on mRNA levels of developmentally relevant genes in sheep oocytes and granulosa cells. Reproduction 2008, 136: 303–312. doi: 10.1530/REP-07-0394. pmid:18515315
- 37. Daoud N, Mahrous KF, Ezzo OH. Feed restriction as a biostimulant of the production of oocyte, their quality and GDF-9 gene expression in rabbit oocytes. Anim Reprod Sci. 2012, 136: 121–127. doi: 10.1016/j.anireprosci.2012.09.011. pmid:23084759
- 38. Cordier A-G, Leveille P, Dupont C, Tarrade A, Picone O, Larcher T et al. Dietary Lipid and Cholesterol Induce Ovarian Dysfunction and Abnormal LH Response to Stimulation in Rabbits. PLoS ONE 2013 8(5): e63101. doi: 10.1371/journal.pone.0063101. pmid:23690983
- 39. Ramos-Vara J. ATechnical Aspects of Immunohistochemistry. Vet Pathol 2005, 42:405–426.
- 40. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001, 29 (9), e45. pmid:11328886
- 41. Vitt UA, Mazerbourg M, Klein C, Hsueh AJW. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol. Reprod. 2002, 67: 473–480. pmid:12135884
- 42. Martino-Andrade AJ, Morais RN, Spercoski KM, Rossi SC, Vechi MF, Golin M et al.Effects of Tribulus terrestris on endocrine sensitive organs in male and female Wistar rats. J Ethnopharmacol. 2010, 127(1):165–70. doi: 10.1016/j.jep.2009.09.031. pmid:19781624
- 43. Gauthaman K, Adaikan PG. Effect of Tribulus terrestris on nicotinamide adenine dinucleotide phosphate-diaphorase activity and androgen receptors in rat brain. J Ethnopharmacol. 2005, 96(1–2):127–32. pmid:15588660
- 44. Lieberman S. Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical? J. Clin. Endocrinol.Metab. 1996, 81:850–851. pmid:8636315
- 45. Stocco C. Aromatase Expression in the Ovary: Hormonal and Molecular Regulation. Steroids. 2008, 73(5): 473–487. doi: 10.1016/j.steroids.2008.01.017. pmid:18321551
- 46. Tabakova, P., Dimitrov M., Tashkov B., 2012. Kirkoua-Sofia Clinical studies on the preparation Tribestan in women with endocrine infertility or menopausal syndrome. (1984–1987) Available from: http://www.scicompdf.se/tiggarnot/tabakova-HerbPharmUSA.pdf.
- 47. Otsuka F, Yao Z, Lee T- H, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15: Identification of target cells and biological functions. J. Biol. Chem. 2000, 275: 39523–39528. pmid:10998422
- 48. Daniel-Carlier N, Harscoet E, Thepot D, Auguste A, Pailhoux E, Jolivet G. Gonad Differentiation in the Rabbit: Evidence of Species-Specific Features. PLoS ONE 2013 8(4): e60451. doi: 10.1371/journal.pone.0060451. pmid:23593221
- 49. Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, Sharov AA et al. Age-associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet 2004, 13:2263–2278. pmid:15317747
- 50. Hosoe M, Kaneyama K, Ushizawa K, Hayashi K, Takahashi T. Quantitative analysis of bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) gene expression in calf and adult bovine ovaries. Reproductive Biology and Endocrinology 2011, 9:33. Available: http://www.rbej.com/content/9/1/33. doi: 10.1186/1477-7827-9-33. pmid:21401961
- 51. Mazerbourg S, Klein C, Roh J, Kaivo-Oja N, Mottershead DG, Korchynski O et al. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol. 2004, 18:653–665. pmid:14684852
- 52. Otsuka F, McTavish K, Shimasaki S. Integral Role of GDF-9 and BMP-15 in Ovarian Function. Mol Reprod Dev. 2011 January; 78(1): 9–21. doi: 10.1002/mrd.21265. pmid:21226076
- 53. Yeo CX, Gilchrist RB, Lane M. Disruption of bi-directional oocyte-cumulus paracrine signaling during in vitro maturation reduces subsequent mouse oocyte developmental competence. Biology of Reproduction 2009, 80(5):1072–1080. doi: 10.1095/biolreprod.108.073908. pmid:19144958
- 54. Huang Q, Cheung AP, Zhang Y, Huang HF, Auersperg N, Leung PC. Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation. Am J Physiol Endocrinol Metab 2009, 296(6):E1344–1353. doi: 10.1152/ajpendo.90929.2008. pmid:19366876
- 55. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002, 87(3):1337–44. pmid:11889206
- 56. Wei LN, Fang C, Huang R, Li LL, Zhang MF, Liang XY. Change and significance of growth differentiation factor 9 and bone morphogenetic protein expression during oocyte maturation in polycystic ovary syndrome patients with ovarian stimulation. Zhonghua Fu Chan Ke Za Zhi. 2012, 47(11):818–22. pmid:23302121
- 57. Halvorson LM, Chin WW. Gonadotropic hormones: biosynthesis, secretion, receptors, and action. In: Yen SC, Jaffe RB, Barbieri RL (eds), Reproductive Endocrinology. WB Saunders Co, Philadelphia, 1999, pp. 81–109.
- 58. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem. 2001, 276:11387–11392. pmid:11154695
- 59. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Ethier JF. Recruitment and development of the follicle; the roles of the transforming growth factor-beta superfamily. Molecular and Cellular Endocrinology 2002, 191:35–43. pmid:12044917
- 60. Feeney A, Nilsson E, Skinner MK. Epigenetics and transgenerational inheritance in domesticated farm animals. Journal of Animal Science and Biotechnology 2014, 5:48. Available: http://www.jasbsci.com/content/5/1/48. doi: 10.1186/2049-1891-5-48. pmid:25810901
- 61. Ashworth C., Toma L. and Hunter M.. Nutritional effects on oocyte and embryo development in mammals: implications for reproductive efficiency and environmental sustainability. Phil. Trans. R. Soc. B 2009, 364:3351–3361. doi: 10.1098/rstb.2009.0184. pmid:19833647